201 related articles for article (PubMed ID: 18418359)
1. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.
Zhao Z; Yang Y; Walker DL; Davis M
Neuropsychopharmacology; 2009 Jan; 34(2):331-40. PubMed ID: 18418359
[TBL] [Abstract][Full Text] [Related]
2. Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors.
Zhao Z; Davis M
J Neurosci; 2004 Nov; 24(46):10326-34. PubMed ID: 15548646
[TBL] [Abstract][Full Text] [Related]
3. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
Walker DL; Davis M
J Neurosci; 1997 Dec; 17(23):9375-83. PubMed ID: 9364083
[TBL] [Abstract][Full Text] [Related]
4. Expression and conditioned inhibition of fear-potentiated startle after stimulation and blockade of AMPA/Kainate and GABA(A) receptors in the dorsal periaqueductal gray.
Fendt M
Brain Res; 2000 Oct; 880(1-2):1-10. PubMed ID: 11032984
[TBL] [Abstract][Full Text] [Related]
5. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock.
Davis M; Walker DL
Brain Struct Funct; 2014 Nov; 219(6):1969-82. PubMed ID: 23934654
[TBL] [Abstract][Full Text] [Related]
6. Visual pathways involved in fear conditioning measured with fear-potentiated startle: behavioral and anatomic studies.
Shi C; Davis M
J Neurosci; 2001 Dec; 21(24):9844-55. PubMed ID: 11739592
[TBL] [Abstract][Full Text] [Related]
7. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
Walker DL; Paschall GY; Davis M
Learn Mem; 2005; 12(2):120-9. PubMed ID: 15774945
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of fear-potentiated startle.
Davis M
Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
[TBL] [Abstract][Full Text] [Related]
9. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
Walker DL; Ressler KJ; Lu KT; Davis M
J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
[TBL] [Abstract][Full Text] [Related]
10. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
Carvalho MC; Santos JM; Brandão ML
Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
[TBL] [Abstract][Full Text] [Related]
11. Involvement of subcortical and cortical afferents to the lateral nucleus of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
Campeau S; Davis M
J Neurosci; 1995 Mar; 15(3 Pt 2):2312-27. PubMed ID: 7891169
[TBL] [Abstract][Full Text] [Related]
12. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
Campeau S; Miserendino MJ; Davis M
Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
[TBL] [Abstract][Full Text] [Related]
13. Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle.
Groenink L; Joordens RJ; Hijzen TH; Dirks A; Olivier B
Neuroreport; 2000 Jul; 11(10):2285-8. PubMed ID: 10923686
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
Campeau S; Davis M
J Neurosci; 1995 Mar; 15(3 Pt 2):2301-11. PubMed ID: 7891168
[TBL] [Abstract][Full Text] [Related]
15. Fear-potentiated startle: a neural and pharmacological analysis.
Davis M; Falls WA; Campeau S; Kim M
Behav Brain Res; 1993 Dec; 58(1-2):175-98. PubMed ID: 8136044
[TBL] [Abstract][Full Text] [Related]
16. Different regions of the periaqueductal grey are involved differently in the expression and conditioned inhibition of fear-potentiated startle.
Fendt M
Eur J Neurosci; 1998 Dec; 10(12):3876-84. PubMed ID: 9875364
[TBL] [Abstract][Full Text] [Related]
17. Muscimol in the deep layers of the superior colliculus/mesencephalic reticular formation blocks expression but not acquisition of fear-potentiated startle in rats.
Meloni EG; Davis M
Behav Neurosci; 1999 Dec; 113(6):1152-60. PubMed ID: 10636295
[TBL] [Abstract][Full Text] [Related]
18. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle.
Kim M; Campeau S; Falls WA; Davis M
Behav Neural Biol; 1993 Jan; 59(1):5-8. PubMed ID: 8095136
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats.
Zimmerman JM; Maren S
Eur J Neurosci; 2010 May; 31(9):1664-70. PubMed ID: 20525079
[TBL] [Abstract][Full Text] [Related]
20. Conditioned fear in low- and high-anxious rats is differentially regulated by cortical subcortical and midbrain 5-HT(1A) receptors.
Ferreira R; Nobre MJ
Neuroscience; 2014 May; 268():159-68. PubMed ID: 24657773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
